Sorbact® is a registered trademark owned by ABIGO Medical ABlogo

Powerful yet careful

Sorbact® wound dressings against infections

The Sorbact® solution

Based on natural processes and physical interactions, Sorbact® safely removes bacteria to prevent and treat infection without releasing active agents into the wound. Make a good choice for your patients.

The challenge

Wounds of different aetiologies are a challenge for the patient, the health professional and health-care systems. An adequate treatment right from the start may be essential for the final outcome.

Read more

The Sorbact® solution

The killing of bacteria means endotoxins are released from dead cell and cell debris is left in the wound. So, unlike antimicrobial dressings that actively kill bacteria, Sorbact® removes bacteria, irreversibly binding them to its surface to reduce bioburden and support wound healing.

Read more
illustration showing a wound, Sorbact Superabsorbent and a microscopic image with microbes on a Sorbact surface
Area of use

Right from the start. Sorbact® for any kind of wound at all stages


Proven to prevent and treat wound infection

Proven in more than 40 clinical studies and in publications including over 7,000 patients, Sorbact® has more than 30 years of successful use in clinical practice. Today Sorbact® is helping patients in over 65 countries around the world and we are continuing this important work by collecting clinical data.

Read more

ABIGO Medical

ABIGO Medical AB is a Swedish pharmaceutical company that owns, develops, manufactures and markets pharmaceutical products and medical devices.

Read more

Unsupported browser

This site probably won't work great in Internet Explorer. We generally only support the recent versions of major browsers like Chrome, Firefox, Safari and Edge.